Veralto Earnings Call Transcripts
Fiscal Year 2026
-
Q3 sales rose 7.5% and adjusted EPS grew 19.2%, prompting higher full-year EPS guidance. Q4 growth is supported by both segments, acquisitions and digital workflow demand, while cost savings, inflation and Cleanwater1 dilution shape the margin outlook.
-
Q2 saw 7.6% sales growth and 19.4% adjusted EPS increase, with strong free cash flow and raised full-year EPS guidance. Water Quality and PQI segments both accelerated, supported by acquisitions and robust industrial demand. Margin expansion and disciplined capital allocation remain key priorities.
-
The meeting covered director elections, auditor ratification, and executive compensation, with all proposals approved by shareholders. No questions were raised, and final results will be filed in a Form 8-K.
-
Q1 2026 saw 7% sales and 13% adjusted EPS growth, prompting a raised full-year EPS outlook. Strategic M&A, cost optimization, and steady end-market demand support continued momentum, with cost savings expected to ramp in 2027–2028.
Fiscal Year 2025
-
Delivered record 2025 results with 6% sales growth, double-digit adjusted EPS growth, and over $1B free cash flow. 2026 guidance targets continued core sales and margin expansion, with strong recurring revenue and new product launches supporting growth.
-
Q3 delivered 6.9% sales growth, 5.1% core sales growth, and 11% adjusted EPS growth, with strong performance in both Water Quality and PQI segments. Full year guidance was raised for adjusted EPS and free cash flow conversion, supported by robust demand, margin expansion, and a strong balance sheet.
-
Q2 2025 delivered 4.8% core sales growth and 9.4% adjusted EPS growth, with strong performance in both water quality and PQI segments. Full-year adjusted EPS guidance was raised, supported by robust free cash flow and disciplined capital allocation.
-
Q1 2025 delivered strong core sales, margin, and EPS growth, with broad-based gains across segments and geographies. Tariff impacts are being mitigated through pricing, supply chain, and manufacturing actions, while full-year guidance for EPS and margins is reaffirmed.
Fiscal Year 2024
-
Delivered record sales and margin expansion in 2024, exceeding guidance and strengthening the portfolio through strategic M&A and divestitures. 2025 outlook targets continued core sales growth, margin improvement, and robust cash generation despite currency headwinds.
-
Delivered strong Q3 results with 4.6% core sales growth, 19% adjusted EPS growth, and robust margin expansion. Completed the TraceGains acquisition, raised full-year EPS guidance, and maintained a strong balance sheet while navigating headwinds in China.
-
Q2 2024 saw strong core sales and margin expansion, with adjusted EPS up 6% year-over-year and guidance raised for the full year. Both water quality and PQI segments delivered growth, recurring revenue rose, and robust cash flow supported a healthy balance sheet.